|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Children's Healthcare of Atlanta |
|---|---|
| Information provided by: | Children's Healthcare of Atlanta |
| ClinicalTrials.gov Identifier: | NCT00266955 |
Purpose
There is some evidence suggesting ADHD medication interaction could result in mild myocardial ischemia/infarct.
| Condition |
|---|
|
Congenital Disorders |
| Study Type: | Observational |
| Study Design: | Natural History, Longitudinal, Defined Population, Retrospective Study |
| Official Title: | A Retrospective Study of Children With ADHD and Cardiac Symptoms |
| Estimated Enrollment: | 10 |
| Study Start Date: | January 1999 |
Children with no previous cardiac history who have been on Adderall for ADHD, have developed acute cardiac symptoms after the addition of Straterra for the treatment of ADHD.
We wish to do a study of the medication interactions of Straterra and other ADHD medications focusing on the cardiac manifestations.
We will collect the following information on each patient: Medical Record Number, Account number, Dates of Admission, Discharge, Treatment or Death, Information Regarding Cardiac Signs and Symptoms, Medication Information, Age, Weight, Diagnoses
Eligibility| Ages Eligible for Study: | up to 18 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, Georgia | |
| Children's Healthcare of Atlanta | |
| Atlanta, Georgia, United States, 30322 | |
| Principal Investigator: | Martha Clabby, MD | Children's Healthcare of Atlanta |
More Information
| Study ID Numbers: | 04-111 |
| Study First Received: | December 19, 2005 |
| Last Updated: | May 3, 2007 |
| ClinicalTrials.gov Identifier: | NCT00266955 History of Changes |
| Health Authority: | United States: Institutional Review Board |
|
pediatric cardiac ADHD Adderall Straterra |